Yet, due to the limited sample size of patients in these two studies, further research is still needed to confirm these findings and establish the clinical value of TP73 expression as a reliable prognostic predictor for the outcome of cervical cancer patients. The gene discussed is TP73; the disease is cervical carcinoma.